Biologics Development and Manufacturing Testing Market Research Report by Resin Type, Technology, Backing Material, Category, End-use Industry, Region
The imminent patent expiration of many biopharmaceutical products can turn out the possibility for generic versions of these therapeutic agents (i.e. biosimilar). However, there are variety of problems that will build approval of biosimilar rather more complicated than the approval of generic equivalents of standard prescribed drugs. These problems center on the intrinsic quality of biopharmaceutical agents, which area unit recombinant proteins in most cases, and the no uniformity of proteins made by completely different manufacturing processes (i.e. variations in host cells, purification and process, formulation and packaging). Major factors driveling by the increasing incorporation of biologics into the healthcare sector’s operations in recent years. Growing realization of the efficacy of biologics in treating stubborn conditions such as rheumatoid arthritis, diabetes, and cancer is likely to drive the global biologics market over the forecast period. Biologics have been shown to be both more effective and safer in medical applications than conventional medicine, leading to their growing usage in the global healthcare sector. Global Biologics Market Size is expected to reach a valuation of USD 285,525 million by the end of the forecast period from 2018 to 2023 with 7% CAGR over the forecast period.
The global Biologics Development and Manufacturing Testing market is expected to be around US$ 8 Billion by 2028, at a CAGR of 14% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/biologics-development-and-manufacturing-testing-market
Market Insights
The global Biologics Development and Manufacturing Testing market is segregated on the basis of Test Objective as Cell Processing, Cell Preservation, Distribution, and Handling, and Process Monitoring and Quality Control. Based on Test Application the global Biologics Development and Manufacturing Testing market is segmented in Market Breakdown by Test Application, Endotoxin Testing, Sterility Testing, Adventitious Agent Detection, Bioburden Testing, and Residual Host Contaminant (Host Cell Protein) Detection Testing. Based on Test Technology the global Biologics Development and Manufacturing Testing market is segmented in In Vivo Safety Testing, Toxicity-LD50 Test, Mutagenicity and Carcinogenicity, Toxic kinetics and ADME, Metabolic Toxicity, Pyrogenic Testing, Embryo toxicity, Endocrine Disruptors, Toxic genomics, and Cell Analysis.
The global Biologics Development and Manufacturing Testing market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biologics Development and Manufacturing Testing?market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Admecell Inc., American Type Culture Collection (ATCC), Catalent Inc., Charles River Laboratories, Covance, Eurofins Scientific, Intertek Group PLC, Sekisui XenoTech LLC, Selexis SA, SGS S.A. Corp., and others are among the major players in the global Biologics Development and Manufacturing Testing market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biologics Development and Manufacturing Testing Market has been segmented as below:
The Biologics Development and Manufacturing Testing Market is segmented on the lines of Biologics Development and Manufacturing Testing Market, By Test Objective, Biologics Development and Manufacturing Testing Market, By Test Application, Biologics Development and Manufacturing Testing Market, By Test Technology, Biologics Development and Manufacturing Testing Market, By Region and Biologics Development and Manufacturing Testing Market, By Company.
Biologics Development and Manufacturing Testing Market, By Test Objective this market is segmented on the basis of Cell Processing, Cell Preservation, Distribution, and Handling and Process Monitoring and Quality Control. Biologics Development and Manufacturing Testing Market, By Test Application this market is segmented on the basis of Market Breakdown by Test Application, Endotoxin Testing, Sterility Testing, Adventitious Agent Detection, Bioburden Testing and Residual Host Contaminant (Host Cell Protein) Detection Testing. Biologics Development and Manufacturing Testing Market, By Test Technology this market is segmented on the basis of In Vivo Safety Testing, Toxicity-LD50 Test, Mutagenicity and Carcinogenicity, Toxic kinetics and ADME, Metabolic Toxicity, Pyrogenic Testing, Embryo toxicity, Endocrine Disruptors, Toxic genomics and Cell Analysis. Biologics Development and Manufacturing Testing Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Biologics Development and Manufacturing Testing Market, By Company this market is segmented on the basis of Admecell Inc., American Type Culture Collection (ATCC), Catalent Inc., Charles River Laboratories, Covance, Eurofins Scientific, Intertek Group PLC, Sekisui XenoTech LLC, Selexis SA and SGS S.A. Corp.
The report covers:
Report Scope:
The global Biologics Development and Manufacturing Testing market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biologics Development and Manufacturing Testing market share. Major industry players with significant revenue share include Admecell Inc., American Type Culture Collection (ATCC), Catalent Inc., Charles River Laboratories, Covance, Eurofins Scientific, Intertek Group PLC, Sekisui XenoTech LLC, Selexis SA, SGS S.A. Corp., and others.
Reasons to Buy this Report:
Request Sample Report from here: https://www.marketresearchengine.com/biologics-development-and-manufacturing-testing-market
Table of Contents:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
???4.1 Introduction
??????4.2.1 Drivers
??????4.2.2 Restraints
??????4.2.3 Opportunities
??????4.2.4 Challenges
???4.2 Porter's Five Force Analysis
???
5. Biologics Development and Manufacturing Testing Market, By Test Objective
6. Biologics Development and Manufacturing Testing Market, By Test Application
7. Biologics Development and Manufacturing Testing Market, By Test Technology
8. Biologics Development and Manufacturing Testing Market, By Geography
9. Competitive Insights
10. Company Profiles
???10.1 Admecell Inc.
??????10.1.1 Company Overview
??????10.1.2 Product/Service Landscape
??????10.1.3 Financial Overview
??????10.1.4 Recent Developments
???10.2 American Type Culture Collection (ATCC)
??????10.2.1 Company Overview
??????10.2.2 Product/Service Landscape
??????10.2.3 Financial Overview
??????10.2.4 Recent Developments
???10.3 Catalent Inc.
领英推荐
??????10.3.1 Company Overview
??????10.3.2 Product/Service Landscape
??????10.3.3 Financial Overview
??????10.3.4 Recent Developments
???10.4 Charles River Laboratories
??????10.4.1 Company Overview
??????10.4.2 Product/Service Landscape
??????10.4.3 Financial Overview
??????10.4.4 Recent Developments
???10.5 Covance
??????10.5.1 Company Overview
??????10.5.2 Product/Service Landscape
??????10.5.3 Financial Overview
??????10.5.4 Recent Developments
???10.6 Eurofins Scientific
??????10.6.1 Company Overview
??????10.6.2 Product/Service Landscape
??????10.6.3 Financial Overview
??????10.6.4 Recent Developments
???10.7 Intertek Group PLC
??????10.7.1 Company Overview
??????10.7.2 Product/Service Landscape
??????10.7.3 Financial Overview
??????10.7.4 Recent Developments
???10.8 Sekisui XenoTech LLC
??????10.8.1 Company Overview
??????10.8.2 Product/Service Landscape
??????10.8.3 Financial Overview
??????10.8.4 Recent Developments
???10.9 Selexis SA
??????10.9.1 Company Overview
??????10.9.2 Product/Service Landscape
??????10.9.3 Financial Overview
??????10.9.4 Recent Developments
???10.10 SGS S.A. Corp.
??????10.10.1 Company Overview
??????10.10.2 Product/Service Landscape
??????10.10.3 Financial Overview
??????10.10.4 Recent Developments
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Phone: +1-855-984-1862
Country: United States